KEGG   DRUG: Bictegravir, embitcitabine and tenofovir alafenamideHelp
Entry
D11039            Mixture   Drug                                   

Name
Bictegravir, embitcitabine and tenofovir alafenamide;
Biktarvy (TN)
Product
Component
(Bictegravir [DR:D10909] | Bictegravir sodium [DR:D10910]), Emtricitabine [DR:D01199], (Tenofovir alafenamide [DR:D10428] | Tenofovir alafenamide fumarate [DR:D10605])
Remark
Therapeutic category: 6250
ATC code: J05AR20
Product: D11039<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR20 Emtricitabine, tenofovir alafenamide and bictegravir
      D11039  Bictegravir, embitcitabine and tenofovir alafenamide <US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D11039  Bictegravir, embitcitabine and tenofovir alafenamide
Antiinfectives [br08350.html]
 Antivirals
  D11039
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11039
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11039
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11039
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11039
BRITE hierarchy
Other DBs
PubChem: 354339134
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system